Article Details

Drug Repurposing for COVID-19: What Went Wrong?

Retrieved on: 2021-04-22 19:52:30

Tags for this article:

Click the tags to see associated articles and topics

Drug Repurposing for COVID-19: What Went Wrong?. View article details on hiswai:

Excerpt

... agents investigated in NIH's ACTIV trials, 47% are monoclonal or polyclonal antibodies (seven monoclonal antibodies and one polyclonal antibody).

Article found on: www.medpagetoday.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up